by Jay Nanduri | Apr 24, 2024 | Technology
Truveta recently won the SXSW Innovation Award for Artificial Intelligence, which recognized the groundbreaking work we have been doing to apply modern generative AI technology to healthcare data and analytics. This comes just a little under a year after our...
by Truveta Staff | Apr 18, 2024 | Technology
In 2019, the US government unveiled the ambitious Ending the HIV Epidemic (EHE) plan, aiming to slash new HIV infections by 90% by 2030. Thanks to advances in antiretroviral therapy (ART), proven models of prevention, and data access, new HIV infections declined 12%...
by Truveta Staff | Apr 17, 2024 | Research, Technology
Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout March 2024 (-32.4%) compared to February 2024. For infants and children, we see a slight increase in respiratory virus-associated hospitalizations; however, rates are...
by Truveta Staff | Apr 8, 2024 | Research, Technology
Truveta Research explored the monthly trends in the incidence of syphilis among US adults from January 2019 to December 2023. During the early months of the COVID-19 pandemic, the rate of syphilis incidence (e.g., new infection) increased significantly, reaching a...
by Truveta Staff | Apr 4, 2024 | Technology
US spending on medical devices and in-vitro diagnostics totals more than $199 billion a year, with most of the costs associated with clinical development. Label expansion provides a pathway for recouping costs associated with the device development process by...
by Truveta Staff | Apr 2, 2024 | Technology
A common misconception is that drugs and devices must gain explicit approval from the FDA for each specific use before healthcare providers can employ them. However, a practice known as off-label use challenges this notion, revealing a broader landscape of treatment...
by Truveta Research | Apr 2, 2024 | Research, Research Insights
There was a decrease in the rate of amphetamine/dextroamphetamine (Adderall) prescription fills per eligible population starting in the fall of 2022; prescription fill rates were 11.4% lower in the first five months of 2023 compared to the first five months of 2022....
by Truveta Staff | Mar 29, 2024 | Research, Technology
Prior to the new Medicare guidelines going into effect, Truveta Research and Zeke Emanuel, MD, PhD from the University of Pennsylvania, explored the first-time prescribing and dispensing of anti-obesity GLP-1 RA medications for US adults aged 60 to 69 with obesity or...
by Truveta Staff | Mar 18, 2024 | Research, Technology
Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout February 2024 (-20.0%) compared to January 2024. While COVID- and influenza-associated hospitalizations decreased (-26.5% and -22.7%), all other respiratory viruses...
by Truveta Staff | Mar 13, 2024 | News, Technology
Truveta has won the 2024 South by Southwest Innovation Award in Artificial Intelligence for its AI-enabled health research and the Truveta Language Model (TLM). TLM is a large-language, multi-modal AI model for transforming electronic health record (EHR) data into...